Amendment Number 1 to Research, Co-Development and Commercialization Agreement and Research License and Option AgreementResearch, Co-Development and Commercialization Agreement and Research License and Option Agreement • March 16th, 2007 • Neose Technologies Inc • Medicinal chemicals & botanical products
This Amendment Number 1 (the “Amendment”) to the Collaboration Agreement and the License Agreement (both as defined below) is effective as of October 20, 2006 (the “Effective Date”), and is by and between BioGeneriX AG, a corporation organized under the laws of the Federal Republic of Germany (“BioGeneriX”), and Neose Technologies, Inc., a corporation organized and existing under the laws of the state of Delaware (“Neose”).
